Log in or Sign up for Free to view tailored content for your specialty!
Breast Cancer News
Long-acting intrauterine contraceptive device may raise breast cancer risk
Using a levonorgestrel-releasing intrauterine system device to prevent pregnancy increased risk for breast cancer among women living in Denmark aged 15 to 49 years, according to a research letter published in JAMA.
Racial disparities in AYA cancers highlight need for targeted interventions
Stage at diagnosis and survival among younger individuals with cancer varied considerably by race, according to a retrospective cohort study.
Log in or Sign up for Free to view tailored content for your specialty!
Patient advocate-led study reveals need for dosing reform in metastatic breast cancer
Innovative dosing strategies are warranted to improve the well-being of individuals with metastatic breast cancer, according to a patient advocate-led study published in JCO Oncology Practice.
FDA approves Itovebi regimen for advanced breast cancer
The FDA approved inavolisib as part of combination therapy for certain adults with breast cancer.
MS linked to greater risk for certain cancers
People with MS had an increased risk for bladder, brain and cervical cancers compared with people without MS, according to a new study in Neurology, the medical journal of the American Academy of Neurology.
Cancer clinical trials commonly use ‘two most inaccurate’ tests to measure kidney function
Most cancer clinical trials use inaccurate tests to evaluate kidney function when determining participant eligibility, according to results of a cross-sectional study.
‘Comprehensive training’ needed to eliminate cancer care barriers for transgender individuals
Self-identifying transgender individuals assigned female at birth face three key barriers when seeking care for breast or gynecologic cancers, according to results of a qualitative study published in JAMA Network Open.
Breast Cancer Awareness Month: New insights into lymphedema, genetic testing and AI
Breast Cancer Awareness Month is observed every October.
VIDEO: Data supports ovarian suppression plus endocrine therapy in HER2-positive breast cancer
In a video interview, Nancy Lin, MD, of Dana-Farber Cancer Institute, talked about an analysis of HERA trial data presented at ESMO Congress.
VIDEO: Adjuvant ribociclib shows efficacy in HR-positive, HER2-negative early breast cancer
In a video interview, Nancy Lin, MD, of Dana-Farber Cancer Institute, discussed “interesting updates” from the NATALEE trial presented at ESMO Congress.
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read